Random Allocation: Clinical Trials

1 trial of Random Allocation, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 21Completed 1

Follow Random Allocation: new trials by email Literature Review of Random Allocation trials Research Report on Random Allocation

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study to Evaluate the Safety, PK, and Dose Response of Paltusotine in Subjects With Carcinoid Syndrome
Randomized: 40 mg Paltusotine, Randomized: 80 mg Paltusotine - Carcinoid Syndrome, Carcinoid
Phase 2CompletedCrinetics Pharmaceuticals Inc.362022-04-222026-03-19

Conditions studied

Carcinoid Tumor (1)  ·  Carcinoid Tumors, Intestinal (1)  ·  Neuroendocrine Tumors (1)  ·  Serotonin Syndrome (1)

Sponsors

Crinetics Pharmaceuticals Inc. (1)

Countries

Argentina (1)  ·  Brazil (1)  ·  Canada (1)  ·  Mexico (1)  ·  Peru (1)  ·  Poland (1)  ·  United States (1)